Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Astrid Jeibmann

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Journal of Neuro-Oncology|June 23, 2009
Atypical choroid plexus papilloma: clinical experience in the CPT-SIOP-2000 studyBrigitte Wrede, Martin Hasselblatt, Ove Peters, et al.
The American Journal of Pathology|September 1, 2009
Platelet-derived growth factor receptor expression and activation in choroid plexus tumorsBjörn Koos, Janna Paulsson, Malin Jarvius, et al.
Molecular Cell|November 5, 2021
Histone H3.3 K27M and K36M mutations de-repress transposable elements through perturbation of antagonistic chromatin marksAmel Chaouch, Johannes Berlandi, Carol C L Chen, et al.
Journal of the American Society of Nephrology : JASN|May 18, 2019
Nephrin Signaling Results in Integrin <i>β</i>1 ActivationChristopher Philipp Dlugos, Cara Picciotto, Carolin Lepa, et al.
Neuro-Oncology|February 13, 2020
TSPO imaging-guided characterization of the immunosuppressive myeloid tumor microenvironment in patients with malignant gliomaBastian Zinnhardt, Michael Müther, Wolfgang Roll, et al.
Genome Medicine|June 30, 2025
The CXCL16/CXCR6 axis is linked to immune effector cell-associated neurotoxicity in chimeric antigen receptor (CAR) T cell therapyI-Na Lu, Louisa Müller-Miny, Carolin Krekeler, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|May 17, 2013
Somatostatin receptor subtype 2 (sst₂) is a potential prognostic marker and a therapeutic target in medulloblastomaMarc Remke, Esther Hering, Nicolas U Gerber, et al.
Acta Neuropathologica|December 22, 2016
Gain of 12p encompassing CCND2 is associated with gemistocytic histology in IDH mutant astrocytomasFelix Sahm, Andrey Korshunov, Daniel Schrimpf, et al.
Neuro-Oncology|January 31, 2016
Methylation profiling of choroid plexus tumors reveals 3 clinically distinct subgroupsChristian Thomas, Martin Sill, Vincent Ruland, et al.
Brain Pathology (Zurich, Switzerland)|July 7, 2016
Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcomePascal D Johann, Volker Hovestadt, Christian Thomas, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Journal of Neuro-Oncology|June 23, 2009
Atypical choroid plexus papilloma: clinical experience in the CPT-SIOP-2000 studyBrigitte Wrede, Martin Hasselblatt, Ove Peters, et al.
The American Journal of Pathology|September 1, 2009
Platelet-derived growth factor receptor expression and activation in choroid plexus tumorsBjörn Koos, Janna Paulsson, Malin Jarvius, et al.
Molecular Cell|November 5, 2021
Histone H3.3 K27M and K36M mutations de-repress transposable elements through perturbation of antagonistic chromatin marksAmel Chaouch, Johannes Berlandi, Carol C L Chen, et al.
Journal of the American Society of Nephrology : JASN|May 18, 2019
Nephrin Signaling Results in Integrin <i>β</i>1 ActivationChristopher Philipp Dlugos, Cara Picciotto, Carolin Lepa, et al.
Neuro-Oncology|February 13, 2020
TSPO imaging-guided characterization of the immunosuppressive myeloid tumor microenvironment in patients with malignant gliomaBastian Zinnhardt, Michael Müther, Wolfgang Roll, et al.
Genome Medicine|June 30, 2025
The CXCL16/CXCR6 axis is linked to immune effector cell-associated neurotoxicity in chimeric antigen receptor (CAR) T cell therapyI-Na Lu, Louisa Müller-Miny, Carolin Krekeler, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|May 17, 2013
Somatostatin receptor subtype 2 (sst₂) is a potential prognostic marker and a therapeutic target in medulloblastomaMarc Remke, Esther Hering, Nicolas U Gerber, et al.
Acta Neuropathologica|December 22, 2016
Gain of 12p encompassing CCND2 is associated with gemistocytic histology in IDH mutant astrocytomasFelix Sahm, Andrey Korshunov, Daniel Schrimpf, et al.
Neuro-Oncology|January 31, 2016
Methylation profiling of choroid plexus tumors reveals 3 clinically distinct subgroupsChristian Thomas, Martin Sill, Vincent Ruland, et al.
Brain Pathology (Zurich, Switzerland)|July 7, 2016
Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcomePascal D Johann, Volker Hovestadt, Christian Thomas, et al.
Pageof 10